Company Description
Annabidiol (OTC Link: ACBD) is a publicly traded shell companies company in the Financial Services sector. The company has a market capitalization of $4.0M.
ACBD stock has declined 43.2% over the past year. Shares last traded at $0.8400.
This page provides a comprehensive overview of ACBD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Annabidiol (ACBD) stock last traded at $0.8400. Over the past 12 months, the stock has lost 43.2%. At a market capitalization of $4.0M, ACBD is classified as a micro-cap stock with approximately 40.2M shares outstanding.
Latest News
Annabidiol has 3 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 0 with negative movement. Key topics include acquisition, AI. View all ACBD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Annabidiol (ACBD) currently stands at 9 shares. Over the past 12 months, short interest has decreased by 65.4%. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Annabidiol (ACBD) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
ACBD Company Profile & Sector Positioning
Annabidiol (ACBD) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the OTC Link.
Investors comparing ACBD often look at related companies in the same sector, including WELSBACH TECH METALS ACQU CORP (WTMA), Mdwerks Inc (MDWK), INCEPTION GROWTH ACQUSTN LTD (IGTA), Breeze Holdings (BRZH), and Mountain Crest (MCAG). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ACBD's relative position within its industry.